HOME Research Insight Zoetis, Inc. (U.S.), Merck and Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Sanofi (France), and Boehringer Ingelheim GmbH (Germany) Dominated the Overall APAC Animal Health Market



Zoetis, Inc. (U.S.), Merck and Co., Inc. (U.S.), Eli Lilly and Company (U.S.), Sanofi (France), and Boehringer Ingelheim GmbH (Germany) Dominated the Overall APAC Animal Health Market


The APAC animal health market is fragmented in nature. Along with global players, various regional and local players operate in this market. The parasiticides and antimicrobials & antibiotics market is dominated by Zoetis, Inc. (U.S.), Sanofi (France), Merck and Co., Inc. (U.S.), and Eli Lilly and Company (U.S.). The animal vaccines market is dominated by domestic players such as China Animal Husbandry Industry Co., Ltd. (China), Jinyu Bio-technology Co., Ltd. (China), Qingdao Yebio Bioengineering Co., Ltd. (China), Tianjin Rringpu bio-technology Co., Ltd. (China), Kyoto Biken Laboratories, Inc. (Japan), Bio-Med Private Limited (India), and Indian Immunologicals Ltd. (India), which together accounted for ~75% to 80% of the APAC animal vaccines market.

The leading position of Zoetis, Inc. in the APAC animal health market is mainly due to its strong product portfolio and strong distribution network across APAC countries. The company has its presence in 45 countries and sells its products in more than 100 countries. The company is engaged in manufacturing and selling of veterinary pharmaceutical products such as anti-infectives, parasiticides, vaccines, medicated feed additives, and other pharmaceuticals (pain and sedation, oncology, antiemetic, allergy and dermatology, and reproductive products), and other non-pharmaceuticals (nutritionals as well as products and services in the agribusiness and complementary areas such as biodevices, diagnostics, and genetics). The company primarily focuses on strengthening its animal health product portfolio and aims to maintain customer satisfaction by providing innovative products. In November 2015, Zoetis, Inc. launched Simparica, a chewable ectoparasiticide tablet, to treat and control fleas and ticks in dogs. In order to increase its customer base and maintain its position in the APAC animal health market, the company focuses on various growth strategies such as acquisitions and new product launches. In November 2015, the company acquired PHARMAQ (Norway), one of the leading manufacturers of vaccines for aquaculture.

Merck and Co., Inc. (U.S.) is another significant player in the APAC animal health market. The company has its presence in more than 140 countries with 25 manufacturing sites located in the U.S., Mexico, Brazil, the U.K., France, Germany, Spain, the Netherlands, Germany, Italy, Austria, India, Australia, and New Zealand. The company invested USD 6,704 million, USD 7,180 Million, and USD 7,503 Million on research and development activities in 2015, 2014, and 2013, respectively, to launch new, innovative, and therapeutically effective products.

Sanofi (France) is involved in the research, development, manufacturing, and marketing of healthcare products for humans and animals. The company offers a wide range of animal health products through Merial, the animal health division of the company. The company’s strong presence in more than 100 countries and its vast R&D activities are its major strengths. To maintain its leading position in the animal health market, Merial focuses on delivering effective, novel, safe, and cost-effective animal health products. Merial strategically pursues various growth strategies such as product launches, product acquisitions, acquisitions, and agreements. The company focuses on strengthening its presence in the emerging markets, such as China, India, and Brazil. In 2013, Merial acquired the healthcare business of Dosch Pharmaceuticals Private Limited (India), which helped the company to strengthen its market presence in India. In 2015, the company signed a business exchange agreement with Boehringer Ingelheim (Germany), one of the leading players in animal health products. Under this agreement, Sanofi will exchange its animal health business (Merial) with the consumer healthcare (CHC) business of Boehringer Ingelheim.

Related Reports:

Asia-Pacific Animal Health Market by Product (Parasiticides (Endoparasiticides, Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive (Vitamin, Amino Acids, Antioxidant), Growth Promoter), Animal (Livestock, Companion) - Forecast to 2021

Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports